Renaissance Technologies’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-203,000
| Closed | -$7.99M | – | 4307 |
|
|
2023
Q2 | $7.99M | Buy |
203,000
+13,300
| +7% | +$469K | 0.01% | 1148 |
|
|
2023
Q1 | $4.62M | Buy |
189,700
+176,100
| +1,295% | +$3.86M | 0.01% | 1518 |
|
|
2022
Q4 | $291K | Buy |
+13,600
| New | +$290K | ﹤0.01% | 3235 |
|
|
2021
Q4 | – | Sell |
-248,300
| Closed | -$4.03M | – | 4322 |
|
|
2021
Q3 | $4.03M | Buy |
+248,300
| New | +$2.7M | 0.01% | 1600 |
|
|
2020
Q4 | – | Sell |
-228,180
| Closed | -$1.29M | – | 3813 |
|
|
2020
Q3 | $1.29M | Sell |
228,180
-893,200
| -80% | -$4.26M | ﹤0.01% | 2375 |
|
|
2020
Q2 | $5.72M | Sell |
1,121,380
-117,600
| -9% | -$490K | ﹤0.01% | 1551 |
|
|
2020
Q1 | $4.26M | Buy |
1,238,980
+178,700
| +17% | +$1.04M | ﹤0.01% | 1663 |
|
|
2019
Q4 | $9.1M | Sell |
1,060,280
-137,975
| -12% | -$493K | 0.01% | 1505 |
|
|
2019
Q3 | $1.34M | Sell |
1,198,255
-35,246
| -3% | -$41K | ﹤0.01% | 2473 |
|
|
2019
Q2 | $1.6M | Buy |
1,233,501
+123,050
| +11% | +$169K | ﹤0.01% | 2448 |
|
|
2019
Q1 | $1.57M | Buy |
1,110,451
+373,551
| +51% | +$522K | ﹤0.01% | 2443 |
|
|
2018
Q4 | $884K | Buy |
736,900
+53,500
| +8% | +$104K | ﹤0.01% | 2637 |
|
|
2018
Q3 | $1.61M | Sell |
683,400
-301,298
| -31% | -$751K | ﹤0.01% | 2387 |
|
|
2018
Q2 | $2.69M | Sell |
984,698
-259,882
| -21% | -$717K | ﹤0.01% | 2123 |
|
|
2018
Q1 | $3.41M | Sell |
1,244,580
-670,720
| -35% | -$1.94M | ﹤0.01% | 2042 |
|
|
2017
Q4 | $5.98M | Sell |
1,915,300
-145,300
| -7% | -$408K | 0.01% | 1696 |
|
|
2017
Q3 | $5.81M | Buy |
2,060,600
+393,500
| +24% | +$1.06M | 0.01% | 1674 |
|
|
2017
Q2 | $4.27M | Sell |
1,667,100
-191,200
| -10% | -$521K | 0.01% | 1811 |
|
|
2017
Q1 | $6.8M | Buy |
+1,858,300
| New | +$7.85M | 0.01% | 1499 |
|
|
2016
Q2 | – | Sell |
-362,500
| Closed | -$15.3M | – | 3560 |
|
|
2016
Q1 | $15.3M | Buy |
362,500
+61,085
| +20% | +$3.11M | 0.03% | 836 |
|
|
2015
Q4 | $23.7M | Sell |
301,415
-76,085
| -20% | -$4.4M | 0.05% | 455 |
|
|
2015
Q3 | $15.3M | Sell |
377,500
-95,850
| -20% | -$5.08M | 0.04% | 645 |
|
|
2015
Q2 | $24.6M | Buy |
473,350
+84,150
| +22% | +$4.19M | 0.06% | 424 |
|
|
2015
Q1 | $18.1M | Buy |
389,200
+372,900
| +2,288% | +$19.4M | 0.04% | 634 |
|
|
2014
Q4 | $731K | Buy |
+16,300
| New | +$685K | ﹤0.01% | 2295 |
|
Renaissance Technologies's ISEE Position: Q3 2023 in Review
Renaissance Technologies sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 203,000 shares — an estimated $7.99M sold.
Renaissance Technologies first reported a position in ISEE in Q4 2014 and held it in 25 quarters. The position peaked at $24.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Renaissance Technologies reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Renaissance Technologies sold 203,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $7.99M.
- Renaissance Technologies first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 25 quarters.
- Renaissance Technologies's IVERIC bio, Inc. Common Stock position peaked at $24.6M in Q2 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.